CPBTD
GILD icon

Central Pacific Bank - Trust Division’s Gilead Sciences GILD Stock Holding History

Central Pacific Bank - Trust Division’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$958K Sell
6,425
-3,164
-33% -$444K 0.1% 185
2026
Q2 		$1.21M Sell
9,589
-205
-2% -$27K 0.12% 172
2026
Q1 		$1.36M Sell
9,794
-2,042
-17% -$286K 0.17% 137
2025
Q4 		$1.45M Sell
11,836
-1,087
-8% -$132K 0.18% 129
2025
Q3 		$1.43M Sell
12,923
-777
-6% -$88.3K 0.17% 132
2025
Q2 		$1.52M Buy
13,700
+83
+0.6% +$8.83K 0.19% 119
2025
Q1 		$1.53M Sell
13,617
-1,541
-10% -$159K 0.21% 124
2024
Q4 		$1.4M Buy
15,158
+894
+6% +$80.5K 0.18% 129
2024
Q3 		$1.2M Sell
14,264
-387
-3% -$29.5K 0.15% 155
2024
Q2 		$1.01M Buy
14,651
+568
+4% +$37.9K 0.12% 178
2024
Q1 		$1.03M Buy
+14,083
New +$1.08M 0.13% 181

Other funds holding GILD

CIM
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
B
Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
CA
CapWealth Advisors Franklin, Tennessee $1.32B AUM 21.6% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
AF
Avanza Fonder Stockholm, Sweden $5.23B AUM 33.79% 1-Year Est. Return

Central Pacific Bank - Trust Division's GILD Position: Q3 2026 in Review

Central Pacific Bank - Trust Division reduced its Gilead Sciences (GILD) stake by 33% in Q3 2026, selling an estimated $444K and leaving 6,425 shares worth $958K. The position accounts for 0.1% of the portfolio, ranked #185.

Central Pacific Bank - Trust Division first reported a position in GILD in Q1 2024 and has held it in 11 quarters since. The position peaked at $1.53M in Q1 2025. 233 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Central Pacific Bank - Trust Division held 6,425 shares of Gilead Sciences worth $958K as of Q3 2026.
  • Central Pacific Bank - Trust Division sold 3,164 Gilead Sciences shares in Q3 2026, an estimated $444K.
  • Gilead Sciences made up 0.1% of Central Pacific Bank - Trust Division's portfolio in Q3 2026, its #185 holding.
  • Central Pacific Bank - Trust Division first reported a position in Gilead Sciences in Q1 2024 and has held it in 11 quarters since.
  • Central Pacific Bank - Trust Division's Gilead Sciences position peaked at $1.53M in Q1 2025.
  • 233 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q3 2026, filed 6 Oct 2026.